{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:22:08Z","timestamp":1787829728740,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Natural Science Foundation of Shandong Province","award":["81902418"],"award-info":[{"award-number":["81902418"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Chronic lung diseases are common among middle-aged and older adults in China. Because remnant cholesterol (RC) and systemic inflammation may jointly contribute to respiratory disease risk, simple blood-based composite markers may help identify individuals at higher risk. We conducted a cross-sectional analysis of the China Health and Retirement Longitudinal Study using biomarker data collected in 2011 and 2015. The study included 7694 adults aged\u2005\u2265\u200545 years with complete lipid and inflammation measurements at both time points. We calculated the RC inflammatory index (RCII), which integrates RC and high-sensitivity C-reactive protein, and constructed a time-weighted cumulative RCII between 2011 and 2015. Chronic lung disease was defined as a self-reported physician diagnosis of chronic bronchitis, emphysema, or chronic pulmonary heart disease. Multivariable logistic regression models were used to estimate associations. Overall, 968 participants (12.6%) reported chronic lung disease (CLD). Higher baseline RCII was associated with higher odds of CLD, with a dose\u2013response pattern across quartiles. In the fully adjusted model, the odds ratios (ORs) across increasing baseline RCII quartiles were 1.18 (95% confidence interval [CI]: 0.83\u20131.50), 1.32 (95% CI: 1.11\u20131.53), and 1.47 (95% CI: 1.15\u20131.79), with the lowest quartile as the reference. Higher cumulative RCII was also associated with CLD, with corresponding ORs of 1.24 (95% CI: 1.07\u20131.44), 1.52 (95% CI: 1.31\u20131.76), and 1.72 (95% CI: 1.45\u20132.05). Higher RCII was independently associated with CLD in middle-aged and older Chinese adults. Although the observed associations were modest in magnitude and the outcome relied on self-reported physician diagnoses, RCII may represent an accessible composite epidemiologic marker warranting further investigation; its value for individual-level risk stratification requires validation through studies incorporating calibration, reclassification, and decision-analytic assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048926","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:06:26Z","timestamp":1780074386000},"page":"e48926","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Remnant cholesterol inflammatory index and chronic lung disease in middle-aged and older Chinese adults: A cross-sectional analysis of the China Health and Retirement Longitudinal Study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7085-5680","authenticated-orcid":false,"given":"Jian","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchen","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Pingyi County People\u2019s Hospital, Linyi, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlong","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8001-4354","authenticated-orcid":false,"given":"Mo","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260827","doi-asserted-by":"crossref","first-page":"638704","DOI":"10.3389\/fpubh.2021.638704","article-title":"Age-related disease burden in China, 1997\u20132017: findings from the global burden of disease study.","volume":"9","author":"Hu","year":"2021","journal-title":"Front Public Health"},{"key":"R2-20260827","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","article-title":"Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.","volume":"391","author":"Wang","year":"2018","journal-title":"Lancet"},{"key":"R3-20260827","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline.","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20260827","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","article-title":"Bronchiectasis.","volume":"4","author":"Chalmers","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20260827","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","article-title":"The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study.","volume":"11","author":"Chen","year":"2023","journal-title":"Lancet Glob Health"},{"key":"R6-20260827","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/VHRM.S104369","article-title":"Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.","volume":"12","author":"Toth","year":"2016","journal-title":"Vasc Health Risk Manag"},{"key":"R7-20260827","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies \u2013 a consensus statement from the European Atherosclerosis Society.","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"R8-20260827","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/eurheartj\/ehac783","article-title":"What is \u201cremnant cholesterol\u201d?","volume":"44","author":"St\u00fcrzebecher","year":"2023","journal-title":"Eur Heart J"},{"key":"R9-20260827","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.3390\/ijms24054268","article-title":"Cholesterol remnants, triglyceride-rich lipoproteins and cardiovascular risk.","volume":"24","author":"Baratta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R10-20260827","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease.","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R11-20260827","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fcvm.2019.00016","article-title":"Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease.","volume":"6","author":"Aday","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"R12-20260827","doi-asserted-by":"crossref","first-page":"160070","DOI":"10.1183\/16000617.0070-2016","article-title":"C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.","volume":"26","author":"Leuzzi","year":"2017","journal-title":"Eur Respir Rev"},{"key":"R13-20260827","doi-asserted-by":"crossref","first-page":"913869","DOI":"10.3389\/fcvm.2022.913869","article-title":"Remnant cholesterol and atherosclerotic cardiovascular disease: metabolism, mechanism, evidence, and treatment.","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R14-20260827","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/2049-6958-8-63","article-title":"The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease.","volume":"8","author":"Agarwal","year":"2013","journal-title":"Multidiscip Respir Med"},{"key":"R15-20260827","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1001\/jama.2013.5732","article-title":"Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.","volume":"309","author":"Thomsen","year":"2013","journal-title":"JAMA"},{"key":"R16-20260827","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12944-025-02580-z","article-title":"Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese national population surveys.","volume":"24","author":"Wang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"R17-20260827","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jare.2024.12.015","article-title":"Predictive value of remnant cholesterol inflammatory index for stroke risk: evidence from the China Health and Retirement Longitudinal Study.","volume":"76","author":"Chen","year":"2025","journal-title":"J Adv Res"},{"key":"R18-20260827","doi-asserted-by":"crossref","first-page":"117141","DOI":"10.1016\/j.atherosclerosis.2023.05.010","article-title":"Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.","volume":"379","author":"Doi","year":"2023","journal-title":"Atherosclerosis"},{"key":"R19-20260827","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","article-title":"Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.","volume":"42","author":"Quispe","year":"2021","journal-title":"Eur Heart J"},{"key":"R20-20260827","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS).","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R21-20260827","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1465-9921-14-24","article-title":"Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease.","volume":"14","author":"Ferrari","year":"2013","journal-title":"Respir Res"},{"key":"R22-20260827","doi-asserted-by":"crossref","first-page":"e1199","DOI":"10.7717\/peerj.1199","article-title":"Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis.","volume":"3","author":"Wei","year":"2015","journal-title":"PeerJ"},{"key":"R23-20260827","doi-asserted-by":"crossref","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019.","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J"},{"key":"R24-20260827","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.","volume":"138","author":"Barnes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R25-20260827","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1164\/rccm.201810-1860SO","article-title":"Chronic obstructive pulmonary disease biomarkers and their interpretation.","volume":"199","author":"Stockley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-20260827","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4155\/fmc-2016-0072","article-title":"Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets.","volume":"8","author":"Moss","year":"2016","journal-title":"Future Med Chem"},{"key":"R27-20260827","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease.","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:01:36Z","timestamp":1787828496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":27,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048926","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2026-02-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}